Skip to main content
Erschienen in: Strahlentherapie und Onkologie 10/2017

31.05.2017 | Original Article

Planning benchmark study for SBRT of early stage NSCLC

Results of the DEGRO Working Group Stereotactic Radiotherapy

verfasst von: Dr. Christos Moustakis, Dipl.-Phys, Oliver Blanck, Fatemeh Ebrahimi Tazehmahalleh, Mark ka heng Chan, Iris Ernst, Thomas Krieger, Marciana-Nona Duma, Markus Oechsner, Ute Ganswindt, Christian Heinz, Horst Alheit, Hilbert Blank, Ursula Nestle, Rolf Wiehle, Christine Kornhuber, Christian Ostheimer, Cordula Petersen, Gerhard Pollul, Wolfgang Baus, Georg Altenstein, Eric Beckers, Katrin Jurianz, Florian Sterzing, Matthias Kretschmer, Heinrich Seegenschmiedt, Torsten Maass, Stefan Droege, Ulrich Wolf, Juergen Schoeffler, Uwe Haverkamp, Hans Theodor Eich, Matthias Guckenberger

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 10/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim was to evaluate stereotactic body radiation therapy (SBRT) treatment planning variability for early stage nonsmall cell lung cancer (NSCLC) with respect to the published guidelines of the Stereotactic Radiotherapy Working Group of the German Society for Radiation Oncology (DEGRO).

Materials and methods

Planning computed tomography (CT) scan and the structure sets (planning target volume, PTV; organs at risk, OARs) of 3 patients with early stage NSCLC were sent to 22 radiotherapy departments with SBRT experience: each department was asked to prepare a treatment plan according to the DEGRO guidelines. The prescription dose was 3 fractions of 15 Gy to the 65% isodose.

Results

In all, 87 plans were generated: 36 used intensity-modulated arc therapy (IMAT), 21 used three-dimensional conformal radiation therapy (3DCRT), 6 used static field intensity-modulated radiation therapy (SF-IMRT), 9 used helical radiotherapy and 15 used robotic radiosurgery. PTV dose coverage and simultaneously kept OARs doses were within the clinical limits published in the DEGRO guidelines. However, mean PTV dose (mean 58.0 Gy, range 52.8–66.4 Gy) and dose conformity indices (mean 0.75, range 0.60–1.00) varied between institutions and techniques (p ≤ 0.02). OARs doses varied substantially between institutions, but appeared to be technique independent (p = 0.21).

Conclusion

All studied treatment techniques are well suited for SBRT of early stage NSCLC according to the DEGRO guidelines. Homogenization of SBRT practice in Germany is possible through the guidelines; however, detailed treatment plan characteristics varied between techniques and institutions and further homogenization is warranted in future studies and recommendations. Optimized treatment planning should always follow the ALARA (as low as reasonably achievable) principle.
Literatur
1.
Zurück zum Zitat Rocco G, Morabito A, Leone A et al (2016) Management of non-small cell lung cancer in the era of personalized medicine. Int J Biochem Cell Biol 78:173–179CrossRefPubMed Rocco G, Morabito A, Leone A et al (2016) Management of non-small cell lung cancer in the era of personalized medicine. Int J Biochem Cell Biol 78:173–179CrossRefPubMed
2.
Zurück zum Zitat Guckenberger M, Allgauer M, Appold S et al (2013) Safety and efficacy of stereotactic body radiotherapy for stage I non-small-cell lung cancer in routine clinical practice. Patterns-of-care and outcome analysis. J Thorac Oncol 8(8):1050–1058CrossRefPubMed Guckenberger M, Allgauer M, Appold S et al (2013) Safety and efficacy of stereotactic body radiotherapy for stage I non-small-cell lung cancer in routine clinical practice. Patterns-of-care and outcome analysis. J Thorac Oncol 8(8):1050–1058CrossRefPubMed
3.
Zurück zum Zitat Cascales A, Martinetti F, Belemsagha D et al (2014) Challenges in the treatment of early non-small cell lung cancer: what is the standard, what are the challenges and what is the future for radiotherapy? Transl Lung Cancer Res 3(4):195–204PubMedPubMedCentral Cascales A, Martinetti F, Belemsagha D et al (2014) Challenges in the treatment of early non-small cell lung cancer: what is the standard, what are the challenges and what is the future for radiotherapy? Transl Lung Cancer Res 3(4):195–204PubMedPubMedCentral
4.
Zurück zum Zitat Maquilan G, Timmerman R (2016) Stereotactic body radiation therapy for early-stage lung cancer. Cancer J 22(4):274–279CrossRefPubMed Maquilan G, Timmerman R (2016) Stereotactic body radiation therapy for early-stage lung cancer. Cancer J 22(4):274–279CrossRefPubMed
5.
Zurück zum Zitat Chang JY, Senan S, Paul MA et al (2015) Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol 16(6):630–637CrossRefPubMedPubMedCentral Chang JY, Senan S, Paul MA et al (2015) Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol 16(6):630–637CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Guckenberger M, Klement RJ, Allgäuer M et al (2016) Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy. Radiother Oncol 118(3):485–491CrossRefPubMed Guckenberger M, Klement RJ, Allgäuer M et al (2016) Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy. Radiother Oncol 118(3):485–491CrossRefPubMed
7.
Zurück zum Zitat Guckenberger M, Andratschke N, Alheit H et al (2014) Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer. Strahlenther Onkol 190(1):26–33CrossRefPubMed Guckenberger M, Andratschke N, Alheit H et al (2014) Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer. Strahlenther Onkol 190(1):26–33CrossRefPubMed
8.
Zurück zum Zitat Büther F, Ernst I, Dawood M et al (2010) Detection of respiratory tumour motion using intrinsic list mode-driven gating in positron emission tomography. Eur J Nucl Med Mol Imaging 37(12):2315–2327CrossRefPubMed Büther F, Ernst I, Dawood M et al (2010) Detection of respiratory tumour motion using intrinsic list mode-driven gating in positron emission tomography. Eur J Nucl Med Mol Imaging 37(12):2315–2327CrossRefPubMed
9.
Zurück zum Zitat ICRU (1993) Prescribing, recording and reporting photon beam therapy. J ICRU os26(1):NP (ICRU Report 50) ICRU (1993) Prescribing, recording and reporting photon beam therapy. J ICRU os26(1):NP (ICRU Report 50)
10.
Zurück zum Zitat ICRU (1999) Prescribing, recording and reporting photon beam therapy (Supplement to ICRU Report 50). J ICRU os32(1):NP (ICRU Report 62) ICRU (1999) Prescribing, recording and reporting photon beam therapy (Supplement to ICRU Report 50). J ICRU os32(1):NP (ICRU Report 62)
11.
Zurück zum Zitat ICRU (2010) Prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy (IMRT). J ICRU 10(1):NP (ICRU Report 83) ICRU (2010) Prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy (IMRT). J ICRU 10(1):NP (ICRU Report 83)
12.
Zurück zum Zitat van’t Riet A, Mak AC, Moerland MA et al (1997) A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: application to the prostate. Int J Radiat Oncol Biol Phys 37(3):731–736CrossRef van’t Riet A, Mak AC, Moerland MA et al (1997) A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: application to the prostate. Int J Radiat Oncol Biol Phys 37(3):731–736CrossRef
13.
Zurück zum Zitat Knöös T, Kristensen I, Nilsson P (1998) Volumetric and dosimetric evaluation of radiation treatment plans: radiation conformity index. Int J Radiat Oncol Biol Phys 42(5):1169–1176CrossRefPubMed Knöös T, Kristensen I, Nilsson P (1998) Volumetric and dosimetric evaluation of radiation treatment plans: radiation conformity index. Int J Radiat Oncol Biol Phys 42(5):1169–1176CrossRefPubMed
14.
Zurück zum Zitat Paddick I (2000) A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note. J Neurosurg 93(Suppl 3):219–222PubMed Paddick I (2000) A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note. J Neurosurg 93(Suppl 3):219–222PubMed
15.
Zurück zum Zitat Lomax NJ, Scheib SG (2003) Quantifying the degree of conformity in radiosurgery treatment planning. Int J Radiat Oncol Biol Phys 55(5):1409–1419CrossRefPubMed Lomax NJ, Scheib SG (2003) Quantifying the degree of conformity in radiosurgery treatment planning. Int J Radiat Oncol Biol Phys 55(5):1409–1419CrossRefPubMed
16.
Zurück zum Zitat Wagner TH, Bova FJ, Friedman WA et al (2003) A simple and reliable index for scoring rival stereotactic radiosurgery plans. Int J Radiat Oncol Biol Phys 57(4):1141–1149CrossRefPubMed Wagner TH, Bova FJ, Friedman WA et al (2003) A simple and reliable index for scoring rival stereotactic radiosurgery plans. Int J Radiat Oncol Biol Phys 57(4):1141–1149CrossRefPubMed
17.
Zurück zum Zitat Wu VW, Kwong DL, Sham JS (2004) Target dose conformity in 3‑dimensional conformal radiotherapy and intensity modulated radiotherapy. Radiother Oncol 71(2):201–206CrossRefPubMed Wu VW, Kwong DL, Sham JS (2004) Target dose conformity in 3‑dimensional conformal radiotherapy and intensity modulated radiotherapy. Radiother Oncol 71(2):201–206CrossRefPubMed
18.
Zurück zum Zitat Van Gellekom MP, Moerland MA, Battermann JJ et al (2004) MRI-guided prostate brachytherapy with single needle method – a planning study. Radiother Oncol 71(3):327–332CrossRefPubMed Van Gellekom MP, Moerland MA, Battermann JJ et al (2004) MRI-guided prostate brachytherapy with single needle method – a planning study. Radiother Oncol 71(3):327–332CrossRefPubMed
19.
Zurück zum Zitat Kataria T, Sharma K, Subramani V et al (2012) Homogeneity Index: An objective tool for assessment of conformal radiation treatments. J Med Phys 37(4):207–213CrossRefPubMedPubMedCentral Kataria T, Sharma K, Subramani V et al (2012) Homogeneity Index: An objective tool for assessment of conformal radiation treatments. J Med Phys 37(4):207–213CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Haverkamp U, Norkus D, Kriz J et al (2014) Optimization by visualization of indices. Strahlenther Onkol 190(11):1053–1059CrossRefPubMed Haverkamp U, Norkus D, Kriz J et al (2014) Optimization by visualization of indices. Strahlenther Onkol 190(11):1053–1059CrossRefPubMed
21.
Zurück zum Zitat Blanck O, Wang L, Baus W et al (2016) Inverse treatment planning for spinal robotic radiosurgery: an international multi-institutional benchmark trial. J Appl Clin Med Phys 17(3):6151CrossRef Blanck O, Wang L, Baus W et al (2016) Inverse treatment planning for spinal robotic radiosurgery: an international multi-institutional benchmark trial. J Appl Clin Med Phys 17(3):6151CrossRef
22.
Zurück zum Zitat Song DY, Kavanagh BD, Benedict SH et al (2004) Stereotactic body radiation therapy. Rationale, techniques, applications, and optimization. Oncology (Williston Park, NY) 18(11):1419–1430 (discussion 1430, 1432, 1435–6) Song DY, Kavanagh BD, Benedict SH et al (2004) Stereotactic body radiation therapy. Rationale, techniques, applications, and optimization. Oncology (Williston Park, NY) 18(11):1419–1430 (discussion 1430, 1432, 1435–6)
23.
Zurück zum Zitat Giglioli FR, Strigari L, Ragona R et al (2016) Lung stereotactic ablative body radiotherapy: A large scale multi-institutional planning comparison for interpreting results of multi-institutional studies. Phys Med 32(4):600–606CrossRefPubMed Giglioli FR, Strigari L, Ragona R et al (2016) Lung stereotactic ablative body radiotherapy: A large scale multi-institutional planning comparison for interpreting results of multi-institutional studies. Phys Med 32(4):600–606CrossRefPubMed
24.
Zurück zum Zitat Zhang GG, Ku L, Dilling TJ et al (2011) Volumetric modulated arc planning for lung stereotactic body radiotherapy using conventional and unflattened photon beams: a dosimetric comparison with 3D technique. Radiat Oncol 6:152CrossRefPubMedPubMedCentral Zhang GG, Ku L, Dilling TJ et al (2011) Volumetric modulated arc planning for lung stereotactic body radiotherapy using conventional and unflattened photon beams: a dosimetric comparison with 3D technique. Radiat Oncol 6:152CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Holt A, van Vliet-Vroegindeweij C, Mans A et al (2011) Volumetric-modulated arc therapy for stereotactic body radiotherapy of lung tumors: a comparison with intensity-modulated radiotherapy techniques. Int J Radiat Oncol Biol Phys 81(5):1560–1567CrossRefPubMed Holt A, van Vliet-Vroegindeweij C, Mans A et al (2011) Volumetric-modulated arc therapy for stereotactic body radiotherapy of lung tumors: a comparison with intensity-modulated radiotherapy techniques. Int J Radiat Oncol Biol Phys 81(5):1560–1567CrossRefPubMed
26.
Zurück zum Zitat Atalar B, Aydin G, Gungor G et al (2012) Dosimetric comparison of robotic and conventional linac-based stereotactic lung irradiation in early-stage lung cancer. Technol Cancer Res Treat 11(3):249–255CrossRefPubMed Atalar B, Aydin G, Gungor G et al (2012) Dosimetric comparison of robotic and conventional linac-based stereotactic lung irradiation in early-stage lung cancer. Technol Cancer Res Treat 11(3):249–255CrossRefPubMed
27.
Zurück zum Zitat Weyh A, Konski A, Nalichowski A et al (2013) Lung SBRT: dosimetric and delivery comparison of RapidArc, TomoTherapy, and IMRT. J Appl Clin Med Phys 14(4):4065CrossRefPubMed Weyh A, Konski A, Nalichowski A et al (2013) Lung SBRT: dosimetric and delivery comparison of RapidArc, TomoTherapy, and IMRT. J Appl Clin Med Phys 14(4):4065CrossRefPubMed
28.
Zurück zum Zitat Chan MK, Kwong DL, Law GM et al (2013) Dosimetric evaluation of four-dimensional dose distributions of CyberKnife and volumetric-modulated arc radiotherapy in stereotactic body lung radiotherapy. J Appl Clin Med Phys 14(4):4229PubMed Chan MK, Kwong DL, Law GM et al (2013) Dosimetric evaluation of four-dimensional dose distributions of CyberKnife and volumetric-modulated arc radiotherapy in stereotactic body lung radiotherapy. J Appl Clin Med Phys 14(4):4229PubMed
29.
Zurück zum Zitat Andratschke N, Parys A, Stadtfeld S et al (2016) Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases. Radiat Oncol 11:74CrossRefPubMedPubMedCentral Andratschke N, Parys A, Stadtfeld S et al (2016) Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases. Radiat Oncol 11:74CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Bibault JE, Mirabel X, Lacornerie T et al (2015) Adapted prescription dose for Monte Carlo algorithm in lung SBRT: clinical outcome on 205 patients. PLOS ONE 10(7):e0133617CrossRefPubMedPubMedCentral Bibault JE, Mirabel X, Lacornerie T et al (2015) Adapted prescription dose for Monte Carlo algorithm in lung SBRT: clinical outcome on 205 patients. PLOS ONE 10(7):e0133617CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Lacornerie T, Lisbona A, Mirabel X et al (2014) GTV-based prescription in SBRT for lung lesions using advanced dose calculation algorithms. Radiat Oncol 9:223CrossRefPubMedPubMedCentral Lacornerie T, Lisbona A, Mirabel X et al (2014) GTV-based prescription in SBRT for lung lesions using advanced dose calculation algorithms. Radiat Oncol 9:223CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Grimm J, LaCouture T, Croce R et al (2011) Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy. J Appl Clin Med Phys 12(2):3368 Grimm J, LaCouture T, Croce R et al (2011) Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy. J Appl Clin Med Phys 12(2):3368
33.
Zurück zum Zitat Ojala JJ, Kapanen MK, Hyödynmaa SJ et al (2014) Performance of dose calculation algorithms from three generations in lung SBRT: comparison with full Monte Carlo-based dose distributions. J Appl Clin Med Phys 15(2):4662CrossRefPubMed Ojala JJ, Kapanen MK, Hyödynmaa SJ et al (2014) Performance of dose calculation algorithms from three generations in lung SBRT: comparison with full Monte Carlo-based dose distributions. J Appl Clin Med Phys 15(2):4662CrossRefPubMed
34.
Zurück zum Zitat Zheng D, Zhu X, Zhang Q et al (2016) Target dose conversion modeling from pencil beam (PB) to Monte Carlo (MC) for lung SBRT. Radiat Oncol 11:83CrossRefPubMedPubMedCentral Zheng D, Zhu X, Zhang Q et al (2016) Target dose conversion modeling from pencil beam (PB) to Monte Carlo (MC) for lung SBRT. Radiat Oncol 11:83CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Darby SC, Ewertz M, McGale P et al (2013) Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 368(11):987–998CrossRefPubMed Darby SC, Ewertz M, McGale P et al (2013) Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 368(11):987–998CrossRefPubMed
36.
Zurück zum Zitat Wang K, Eblan MJ, Deal AM et al (2017) Cardiac toxicity after radiotherapy for stage III non-small-cell lung cancer: pooled analysis of dose-escalation trials delivering 70 to 90 Gy. J Clin Oncol:JCO2016700229. doi:10.1200/JCO.2016.70.0229 Wang K, Eblan MJ, Deal AM et al (2017) Cardiac toxicity after radiotherapy for stage III non-small-cell lung cancer: pooled analysis of dose-escalation trials delivering 70 to 90 Gy. J Clin Oncol:JCO2016700229. doi:10.​1200/​JCO.​2016.​70.​0229
37.
Zurück zum Zitat Keall PJ, Mageras GS, Balter JM et al (2016) The management of respiratory motion in radiation oncology report of AAPM Task Group 76. Med Phys 33(10):3874–3900CrossRef Keall PJ, Mageras GS, Balter JM et al (2016) The management of respiratory motion in radiation oncology report of AAPM Task Group 76. Med Phys 33(10):3874–3900CrossRef
38.
Zurück zum Zitat Benedict SH, Yenice KM, Followill D et al (2010) Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys 37(8):4078–4101CrossRefPubMed Benedict SH, Yenice KM, Followill D et al (2010) Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys 37(8):4078–4101CrossRefPubMed
Metadaten
Titel
Planning benchmark study for SBRT of early stage NSCLC
Results of the DEGRO Working Group Stereotactic Radiotherapy
verfasst von
Dr. Christos Moustakis, Dipl.-Phys
Oliver Blanck
Fatemeh Ebrahimi Tazehmahalleh
Mark ka heng Chan
Iris Ernst
Thomas Krieger
Marciana-Nona Duma
Markus Oechsner
Ute Ganswindt
Christian Heinz
Horst Alheit
Hilbert Blank
Ursula Nestle
Rolf Wiehle
Christine Kornhuber
Christian Ostheimer
Cordula Petersen
Gerhard Pollul
Wolfgang Baus
Georg Altenstein
Eric Beckers
Katrin Jurianz
Florian Sterzing
Matthias Kretschmer
Heinrich Seegenschmiedt
Torsten Maass
Stefan Droege
Ulrich Wolf
Juergen Schoeffler
Uwe Haverkamp
Hans Theodor Eich
Matthias Guckenberger
Publikationsdatum
31.05.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Strahlentherapie und Onkologie / Ausgabe 10/2017
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-017-1151-8

Weitere Artikel der Ausgabe 10/2017

Strahlentherapie und Onkologie 10/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.